MenüForum-NavigationForumMitgliederAnmeldenRegistrierenForum-Breadcrumbs - Du bist hier:ForumFlohmarkt: AllgemeineskmqacaAntwortenAntworten: kmqaca <blockquote><div class="quotetitle">Zitat von Gast am 31. März 2026, 14:51 Uhr</div>[url=https://febs.onlinelibrary.wiley.com/doi/10.1016/j.febslet.2005.03.012]Zoya Demidenko[/url]: Scientist in Oncology Science [url=https://www.aging-us.com/article/100421/]Zoya Demidenko[/url] is a distinguished investigator connected with the Division of Cell Stress Science at Roswell Park Cancer Institute in Buffalo, New York. Previously, she was employed at the National Institutes of Health and New York Medical College, developing a strong background in clinical investigation. Demidenko's scientific contributions encompasses a number of key areas, including the PI3K/AKT/mTOR signaling cascade, cell cycle control, cellular aging, and cancer science. To date, she has co-authored more than 46 academic articles, which have received more than 4,100 references — a reflection to the influence of her research. Among her most notable contributions lies in explaining the pathways of cell aging. Her work revealed that when the cellular division cycle is arrested but cellular expansion persists, cells enter senescence. Crucially, [url=https://febs.onlinelibrary.wiley.com/doi/10.1016/j.febslet.2005.03.012]Zoya Demidenko[/url] established that this transition is pharmacologically suppressed using compounds such as mTOR inhibitors. [url=https://aacrjournals.org/cancerres/article/65/16/7386/518098/Depletion-of-Mutant-p53-and-Cytotoxicity-of?guestAccessKey=]Zoya Demidenko[/url] has additionally brought substantially to cancer treatment investigation, notably in the field of selective cell protection — a approach aimed at shielding non-cancerous cells from anticancer drugs whilst leaving tumor cells susceptible. This strategy carries significant hope for diminishing the toxic effects of cancer treatment. Throughout her scientific life, Demidenko has partnered with top investigators worldwide, including Dr. Mikhail Blagosklonny. Her publications appears in leading publications such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene. [31.03.2026 11:21] Папа: With an h-index of 33, [url=https://scholargps.com/scholars/59798749410547/zoya-n-demidenko]Zoya Demidenko[/url] ranks as a influential figure in current cancer science, whose findings keep to guide our comprehension of how cells grow old, resist treatment, and the ways in which cancer can be more successfully combated. https://moodylab.smhs.gwu.edu/lab-members</blockquote><br> Abbrechen
